Aging and cancer: What oncologists need to know

Geriatric Oncology: Treatment, Assessment and Management

Volumn , Issue , 2009, Pages 1-15

  Hurria, Arti ^a   Balducci, Lodovico ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889987352     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-89070-8_1     Document Type: Chapter

References (65)

1. Diab SG, Elledge RM, Clark GM Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 2000; 92(7): 550-6.
2. Anders CK, Hsu DS, Broadwater G, et al Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 2008; 26 (20): 3324-30.
3. Estey E. Acute myeloid leukemia and myelodysplastic syndromes in older patients. J Clin Oncol 2007; 25 (14): 1908-15.
4. Hutchins LF, Unger JM, Crowley J.J., Coltman CA, Jr., Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341 (27): 2061-7.
5. Yee KW, Pater JL, Pho L, Zee B., Siu LL Enrollment of older patients in cancer treatment trials in Canada: Why is age a barrier? J Clin Oncol 2003; 21 (8): 1618-23.
6. Trimble EL, Carter CL, Cain D, Freidlin B., Ungerleider RS, Friedman MA Representation of older patients in cancer treatment trials. Cancer 1994; 74 (7 Suppl):2208-14.
7. Muss HB, Berry DA, Cirrincione C, et al Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: The Cancer and Leukemia Group B Experience. J Clin Oncol 2007; 25 (24): 3699-704.
8. Sawhney R, Sehl M, Naeim A. Physiologic aspects of aging: Impact on cancer management and decision making, part I. Cancer J 2005; 11 (6): 449-60.
9. Sehl M, Sawhney R, Naeim A. Physiologic aspects of aging: Impact on cancer management and decision making, part II. Cancer J 2005; 11 (6): 461-73.
10. Vestal RE. Aging and pharmacology. Cancer 1997; 80 (7): 1302-10.
11. Lindeman RD, Tobin J, Shock NW Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33 (4): 278-85.
12. Fehrman-Ekholm I., Skeppholm L. Renal function in the elderly (>70 years old) measured by means of iohexol clearance, serum creatinine, serum urea and estimated clearance. Scand J Urol Nephrol 2004; 38 (1): 73-7.
13. Avorn J, Gurwitz, JH. Geriatric Medicine. Springer-Verlag, New York. 1997.
14. Baker SD, van Schaik RH, Rivory LP, et al Factors affecting cyto-chrome P-450 3A activity in cancer patients. Clin Cancer Res 2004; 10 (24): 8341-50.
15. Hunt CM, Westerkam WR, Stave GM Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 1992; 44 (2): 275-83.
16. Schwartz JB. Race but not age affects erythromycin breath test results in older hypertensive men. J Clin Pharmacol 2001; 41 (3): 324-9.
17. Sotaniemi EA, Arranto AJ, Pelkonen O, Pasanen M. Age and cyto-chrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions. Clin Pharmacol Ther 1997; 61 (3): 331-9.
18. Yuen GJ. Altered pharmacokinetics in the elderly. Clin Geriatr Med 1990; 6 (2): 257-67.
19. Baker SD, Grochow LB Pharmacology of cancer chemotherapy in the older person. Clin Geriatr Med 1997; 13 (1): 169-83.
20. Lichtman SM, Hollis D, Miller A.A., et al Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762). J Clin Oncol 2006; 24 (12): 1846-51.
21. ten Tije A.J., Verweij J, Carducci M.A., et al Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly. J Clin Oncol 2005; 23 (6): 1070-7.
22. Dees EC, O'Reilly S, Goodman SN, et al A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. Cancer Invest 2000; 18 (6): 521-9.
23. Jen JF, Cutler DL, Pai S.M., et al Population pharmacokinetics of temozolomide in cancer patients. Pharm Res 2000; 17 (10): 1284-9.
24. Smith TJ, Khatcheressian J, Lyman G.H., et al Update of recommendations for the use of white blood cell growth factors: An evidence-based clinical practice guideline. J Clin Oncol 2006; 24 (19): 3187-205.
25. Gomez H, Hidalgo M, Casanova L., et al Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lym-phoma: Results of a multivariate analysis. J Clin Oncol 1998; 16 (6): 2065-9.
26. Balducci L, Al-Halawani H, Charu V., et al Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim. Oncologist 2007; 12 (12): 1416-24.
27. Mancuso A, Migliorino M, De Santis S, Saponiero A, De Marinis F. Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol 2006; 17 (1): 146-50.
28. Rao AV, Cohen HJ Fatigue in older cancer patients: Etiology, assessment, and treatment. Sem Oncol 2008; 35 (6): 633-42.
29. Reuben DB, Rubenstein LV, Hirsch S.H., Hays RD Value of functional status as a predictor of mortality: Results of a prospective study. Am J Med 1992; 93 (6): 663-9.
30. Inouye SK, Peduzzi PN, Robison J.T., Hughes JS, Horwitz RI, Concato J. Importance of functional measures in predicting mortality among older hospitalized patients. J Am Med Assoc 1998; 279 (15): 1187-93.
31. Stafford RS, Cyr PL The impact of cancer on the physical function of the elderly and their utilization of health care. Cancer 1997; 80 (10): 1973-80.
32. Keating NL, Norredam M, Landrum M.B., Huskamp HA, Meara E. Physical and mental health status of older long-term cancer survivors. J Am Geriatr Soc 2005; 53 (12): 2145-52.
33. Audisio RA, Ramesh H, Longo W.E., Zbar AP, Pope D. Preoperative assessment of surgical risk in oncogeriatric patients. Oncologist 2005; 10 (4): 262-8.
34. Maione P, Perrone F, Gallo C., et al Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: A prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 2005; 23 (28): 6865-72.
35. Freyer G, Geay JF, Touzet S, et al Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: A GINECO study. Ann Oncol 2005; 16 (11): 1795-800.
36. Extermann M, Balducci L, Lyman GH What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol 2000; 18 (8): 1709-17.
37. Frasci G, Lorusso V, Panza N., et al Gemcitabine plus vinorel-bine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 2000; 18 (13): 2529-36.
38. Firat S, Bousamra M, Gore E., Byhardt RW Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002; 52 (4): 1047-57.
39. Piccirillo JF, Tierney RM, Costas I, Grove L., Spitznagel EL, Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. J Am Med Assoc 2004; 291 (20): 2441-7.
40. Satariano WA, Ragland DR The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994; 120 (2): 104-10.
41. Steyerberg EW, Neville BA, Koppert L.B., et al Surgical mortality in patients with esophageal cancer: Development and validation of a simple risk score. J Clin Oncol 2006; 24 (26): 4277-84.
42. Birim O, Kappetein AP, van Klaveren RJ, Bogers AJ Prognostic factors in non-small cell lung cancer surgery. Eur J Surg Oncol 2006; 32 (1): 12-23.
43. Meyerhardt JA, Catalano PJ, Haller D.G., et al Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 2003; 21 (3): 433-40.
44. Hammarsten J, Hogstedt B. Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 2005; 41 (18): 2887-95.
45. Goodwin PJ, Ennis M, Pritchard K.I., et al Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study. J Clin Oncol 2002; 20 (1): 42-51.
46. Pavelka JC, Brown RS, Karlan B.Y., et al Effect of obesity on survival in epithelial ovarian cancer. Cancer 2006; 107 (7): 1520-4.
47. Kaklamani VG, Wisinski KB, Sadim M, et al Variants of the adipo-nectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. J Am Med Assoc 2008; 300 (13): 1523-31.
48. Lee SJ, Lindquist K, Segal M.R., Covinsky KE Development and validation of a prognostic index for 4-year mortality in older adults. J Am Med Assoc 2006; 295 (7): 801-8.
49. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47 (11): 1245-51.
50. Walter LC, Brand RJ, Counsell S.R., et al Development and validation of a prognostic index for 1-year mortality in older adults after hospi-talization. J Am Med Assoc 2001; 285 (23): 2987-94.
51. Seeman TE, Berkman LF, Kohout F, Lacroix A., Glynn R, Blazer D. Intercommunity variations in the association between social ties and mortality in the elderly. A comparative analysis of three communities. Ann Epidemiol 1993; 3 (4): 325-35.
52. Kornblith AB, Herndon JE, 2nd, Zuckerman E, et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer 2001; 91 (2): 443-54.
53. Kornblith AB, Herndon JE, 2nd, Weiss RB, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 2003; 98 (4): 679-89.
54. Braun M, Mikulincer M, Rydall A., Walsh A, Rodin G. Hidden morbidity in cancer: Spouse caregivers. J Clin Oncol 2007; 25 (30): 4829-34.
55. Rhee YS, Yun YH, Park S, et al Depression in family caregivers of cancer patients: The feeling of burden as a predictor of depression. J Clin Oncol 2008; 26 (36): 5890-5.
56. Kua J. The prevalence of psychological and psychiatric sequelae of cancer in the elderly-How much do we know? Ann Acad Med Singapore 2005; 34 (3): 250-6.
57. Penninx BW, Guralnik JM, Ferrucci L, Simonsick E.M., Deeg DJ, Wallace RB Depressive symptoms and physical decline in community-dwelling older persons. J Am Med Assoc 1998; 279 (21): 1720-6.
58. Langa KM, Valenstein MA, Fendrick A.M., Kabeto MU, Vijan S. Extent and cost of informal caregiving for older Americans with symptoms of depression. Am J Psychiatry 2004; 161 (5): 857-63.
59. Vinokur AD, Threatt BA, Vinokur-Kaplan D, Satariano WA The process of recovery from breast cancer for younger and older patients. Changes during the first year. Cancer 1990; 65 (5): 1242-54.
60. Miller M, Mogun H, Azrael D., Hempstead K, Solomon DH Cancer and the risk of suicide in older Americans. J Clin Oncol 2008; 26 (29): 4720-4.
61. Wolfson C, Wolfson DB, Asgharian M, et al A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001; 344 (15): 1111-6.
62. Gupta SK, Lamont EB Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc 2004; 52 (10): 1681-7.
63. Gorin SS, Heck JE, Albert S, Hershman D. Treatment for breast cancer in patients with Alzheimer's disease. J Am Geriatr Soc 2005; 53 (11): 1897-904.
64. Hurria A, Goldfarb S, Rosen C., et al Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective. Breast Cancer Res Treat 2006; 98 (3): 343-8.
65. Fried TR, Bradley EH, Towle V.R., Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med 2002; 346 (14): 1061-6.